Monitoring Agency Report for quarter ended September 30, 2026

October 17, 2026 LTTL/L&S/2026-27/10/11 The Listing Department, The Listing Department, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Maharashtra, India Maharashtra, India Dear Sir/Madam, Sub : Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Monitoring Agency Report for the quarter ended September 30, 2026 Ref : Le Travenues Technology Limited (the “Company”) NSE Symbol: IXIGO and BSE Scrip Code: 544192 In compliance with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Monitoring Agency Report issued by CARE Ratings Limited for the quarter ended September 30, 2026, as reviewed by the Audit Committee, at its meeting held today i.e., Saturday, October 17, 2026. This disclosure will also be available on the website of the Company at https://investors.ixigo.com/. This is for your information and records. Thank you, For Le Travenues Technology Limited Suresh Kumar Bhutani (Group General Counsel, Company Secretary & Compliance Officer) CARE/NRO/GEN/2026-27/1132 The Board of Directors Le Travenues Technology Limited October 16, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026- in relation to Preferential Issue (PI) of Le Travenues Technology Limited (“the Company”) We write in our capacity of Monitoring Agency for the Preferential Issue for the amount aggregating to Rs. 1295.56 crore of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended 30/09/2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated November 06, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sahil Goyal Associate Director Sahil.goyal@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Le Travenues Technology Limited For the quarter ended: 30/09/2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Nil Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors after the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Sahil Goyal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Le Travenues Technology Limited Name of the promoter : The Company does not have an identifiable promoter Industry/sector to which it belongs : Travel Industry 2) Issue Details Issue Period : November 12, 2025 (Date of Allotment) Type of issue (public/rights) : Preferential issue of Shares Type of specified securities : Preferential issue of equity shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 1,295.56 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Comments of Source of information / certifications considered by Comments of the the Particulars Reply Monitoring Agency for preparation of report Monitoring Agency Board of Directors Chartered Accountant certificate*, Management Utilization Whether all utilization is as per the disclosures in the Offer Document? Yes Refer Note-1 below No comments certificate, Bank Statement, Board Resolution, Offer Document Whether shareholder approval has been obtained in case of material Not NA NA No comments deviations# from expenditures disclosed in the Offer Document? required Whether the means of finance for the disclosed objects of the issue have Management Utilization certificate, Chartered Accountant No NIL No comments changed? certificate*, Offer Document Is there any major deviation observed over the earlier monitoring agency No deviations over the earlier No Monitoring Agency Report No comments reports? monitoring agency report Whether all Government/statutory approvals related to the object(s) Yes Management Utilization certificate NIL No comments have been obtained? Whether all arrangements pertaining to technical NA Management Utilization certificate NIL No comments assistance/collaboration are in operation? Are there any favorable/unfavorable events affecting the viability of No Management Utilization certificate NIL No comments these object(s)? CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Comments of Source of information / certifications considered by Comments of the the Particulars Reply Monitoring Agency for preparation of report Monitoring Agency Board of Directors Is there any other relevant information that may materially affect the Management Utilization certificate, Chartered Accountant No Refer Note-2 below No comments decision making of the investors? certificate* NA: Not applicable * CA Certificate from S.R. Batliboi & Associates LLP dated October 14, 2026 Note-1: During Q2FY27, the [Showing first 8,000 characters — download PDF for full document]